Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, SAD, and MAD Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IV Treatment of CALY-002 in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis

NCT04593251 is registered in ClinicalTrials.gov with Calypso Biotech BV as lead sponsor.

NCT NCT04593251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04593251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, SAD, and MAD Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IV Treatment of CALY-002 in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
Lead sponsor
Calypso Biotech BV
Phase
Phase 1
Overall status
Completed
Start date
September 28, 2020
Completion date
April 2, 2024
Enrollment
73 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease, eosinophilic esophagitis